The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Smart start: Final results of rituximab, lenalidomide, and ibrutinib lead in prior to combination with chemotherapy for patients with newly diagnosed diffuse large B-cell lymphoma.
 
Jason Westin
Consulting or Advisory Role - Celgene; Genentech/Abbvie; Kite, a Gilead company; Kite/Gilead; Novartis; ProNAi; Spectrum Pharmaceuticals
Research Funding - Bristol-Myers Squibb; Celgene; Genentech; Janssen; Karyopharm Therapeutics; Kite/Gilead; Novartis; ProNAi
 
Loretta J. Nastoupil
Honoraria - Bayer; Celgene; Gilead Sciences; Janssen Oncology; Novartis; Spectrum Pharmaceuticals
Research Funding - Celgene; Genentech/Roche; Janssen Biotech; Karus Therapeutics; LAM Therapeutics; TG Therapeutics
 
Luis Fayad
No Relationships to Disclose
 
Fredrick B. Hagemeister
No Relationships to Disclose
 
Yasuhiro Oki
Employment - Jazz Pharmaceuticals
Honoraria - Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Meiji Seika Kaisha
 
Francesco Turturro
No Relationships to Disclose
 
Sairah Ahmed
No Relationships to Disclose
 
Maria Alma Rodriguez
Research Funding - Amgen (Inst); GlaxoSmithKline (Inst); Ortho Biotech (Inst); Pfizer (Inst)
 
Hun Ju Lee
No Relationships to Disclose
 
Raphael Steiner
No Relationships to Disclose
 
Ranjit Nair
No Relationships to Disclose
 
Simrit Parmar
No Relationships to Disclose
 
Ken H Young
No Relationships to Disclose
 
Timothy McDonnell
No Relationships to Disclose
 
Hubert Chuang
No Relationships to Disclose
 
Michael Richard Green
Research Funding - Genzada Pharmaceuticals
Travel, Accommodations, Expenses - Abbvie
 
Sattva Swarup Neelapu
Honoraria - Bio Ascend; DAVAOncology; Medscape; Physicans' Education Resource
Consulting or Advisory Role - Celgene; Cell Medica; Gilead Sciences; Incyte; Kite, a Gilead company; Merck Sharp & Dohme; Novartis; Pfizer; Precision Biosciences; Unum Therapeutics
Research Funding - Acerta Pharma; Bristol-Myers Squibb; Celgene; Cellectis; Gilead Sciences; Karus Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; Pharmacyclics; poseida therapeutics; Unum Therapeutics
Travel, Accommodations, Expenses - Celgene; Chugai Pharma; DAVAOncology; Kite/Gilead; Medscape; Merck; Novartis; Pfizer; Physicans' Education Resource; Precision Biosciences; Unum Therapeutics
 
Richard Eric Davis
Research Funding - Karus Therapeutics (Inst)